Stocks-ATRA-Atara Biotherapeutics Inc

ATRA Atara Biotherapeutics Inc

1.49 0.01 (0.68%)
Market OpenDelayed Prices By NASDAQ, in USD
Trade
Trade

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2022: Atara Biotherapeutics Inc's revenues increased by 212.55% and amounted to 63.57M. Net income increased by 32.88% to -228.30M. Net assets decreased by 54.71% to 126.64M and EPS increased from -3.63 to -2.24.
ATRA's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
-185.02%
Net Profit Margin
-406.28%
Operating Margin
-4,551.42%
Return On Investment
-92.59%